Spinal & Biologics Business Overview

Listen. Respond. Deliver.

Spinal & Biologics develops and manufactures products that treat a broad spectrum of spine disorders.

Our Spinal & Biologics business is committed to advancing the treatment of spinal conditions, and as the global leader in today’s Spinal & Biologics market, we lead the way in innovative solutions to treating the spine.

A crucial element to this innovation and market leadership is that our business is committed to development of new technologies through collaboration. We work with world-renowned surgeons, researchers and other innovative partners to offer state-of-the-art products and technologies for:

BRYAN^® Cervical Disc

orthopaedics
neurosurgeons
interventional radiologists
treatment of spinal conditions, such as scoliosis, degenerative disc disease, including osteoporosis, spinal stenosis, and the areas of tumour and spinal trauma.

Our key technologies are:

Minimally Invasive Technologies

CD Horizon Longitude Spinal System

Minimal Access Spinal Technologies (MAST™) allow surgeons to operate through small incisions, utilising muscle-sparing techniques by working on the spine through small tubes and retractor systems. Because only small incisions are made, the recovery time after surgery is reduced considerably.

Spinal Fracture Treatment

KYPHON® Balloon Kyphoplasty

Our KYPHON® Balloon Kyphoplasty products offer a minimally invasive treatment option for spinal fractures caused by cancer, osteoporosis or trauma.

Biologics

rhBMP-2

Together with Wyeth Farmaceuticals, Medtronic offers a surgically implantable medicine as part of our biologics platform. This medicine has been developed to initiate bone growth in a specific, targeted area.

Next: Navigation